The use of antioxidants in Friedreich’s ataxia treatment

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.4, 2003-04, pp. : 569-575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Friedreich’s ataxia: iron chelators that target the mitochondrion as a therapeutic strategy?

By Richardson DR

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 235-245

Informa Healthcare

Access to resources Recommend Favorite

Monitoring Cardiac Function During Idebenone Therapy in Friedreich's Ataxia

Current Pharmaceutical Design, Vol. 21, Iss. 4, 2015-02 ,pp. : 479-483

Bentham Science Publishers

Access to resources Recommend Favorite

Idebenone in Friedreich's ataxia

By Tonon Caterina Lodi Raffaele

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2327-2337

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy for Friedreich Ataxia

By Tsou Amy Y.

CNS Drugs, Vol. 23, Iss. 3, 2009-01 ,pp. : 213-223

Adis International

Access to resources Recommend Favorite

Idebenone: a guide to its use in Alzheimer's disease, other age-related cognitive disorders and Friedreich's ataxia

Drugs & Therapy Perspectives, Vol. 26, Iss. 2, 2010-02 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite